Japan Society of Anxiety Disorders and Viatris Pharmaceutical Conclude Partnership Agreement for Generalized Anxiety Disorder (GAD) Disease Awareness
NQ Score
42/100
N1 Content Completeness
5
AI Summary (NQ-processed)
The Japan Society of Anxiety Disorders and Viatris Pharmaceutical have concluded a partnership agreement for Generalized Anxiety Disorder (GAD) disease awareness. This agreement aims to improve GAD recognition and promote early diagnosis and treatment through joint production of public awareness videos and educational videos.